PROCEPT BioRobotics Corporation

PRCT52

$84.99arrow_drop_up2.65%$2.20

PRCT52

$84.99

arrow_drop_up2.65%$2.20

Performance History

Key Stats
Open	$83.22
Prev. Close	$82.79
EPS	-2.06
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	82.13	85.26
52 Week Range	24.83	85.81

Ratios







EPS	-2.06

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About PROCEPT BioRobotics Corporation (PRCT)

PROCEPT BioRobotics Corporation (PRCT) is a medical technology company that specializes in surgical robotics. The company's flagship product, the AquaBeam System, is a novel robotic platform designed to address the needs of patients with benign prostatic hyperplasia (BPH). BPH is a common condition in older men that can cause urinary symptoms and affect quality of life. The AquaBeam System uses a proprietary waterjet technology to precisely remove excess prostate tissue, providing a minimally invasive alternative to traditional surgical approaches. The system offers several advantages, including improved patient outcomes, reduced operating time, and faster recovery.

In recent years, PROCEPT BioRobotics Corporation has gained recognition for its innovative approach to treating BPH. The AquaBeam System has been clinically proven to be safe and effective, with numerous studies demonstrating its efficacy compared to traditional surgical methods. The company has also received regulatory approvals in key markets, including the United States and Europe. This has allowed PROCEPT BioRobotics Corporation to expand its commercial presence and establish partnerships with leading healthcare providers. As a result, the company has seen steady revenue growth and increased market share in the surgical robotics space.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Dr. Reza Zadno Ph.D.
Headquarters: Redwood City
Employees: 428
Exchange: NASDAQ

add PROCEPT BioRobotics Corporation to watchlist

Keep an eye on PROCEPT BioRobotics Corporation

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is PROCEPT BioRobotics Corporation's (PRCT) price per share?

The current price per share for PROCEPT BioRobotics Corporation (PRCT) is $84.99. The stock has seen a price change of $2.2 recently, indicating a 2.66% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for PROCEPT BioRobotics Corporation (PRCT)?

For PROCEPT BioRobotics Corporation (PRCT), the 52-week high is $85.81, which is 0.96% from the current price. The 52-week low is $24.83, the current price is 242.29% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is PROCEPT BioRobotics Corporation (PRCT) a growth stock?

PROCEPT BioRobotics Corporation (PRCT) has shown an average price growth of 0.41% over the past three years. It has received a score of 81 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying PROCEPT BioRobotics Corporation as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is PROCEPT BioRobotics Corporation (PRCT) stock price performance year to date (YTD)?

As of the latest data, PROCEPT BioRobotics Corporation (PRCT) has a year-to-date price change of 105.09%. Over the past month, the stock has experienced a price change of 29.58%. Over the last three months, the change has been 41.32%. Over the past six months, the figure is 69.78%.

help

Is PROCEPT BioRobotics Corporation (PRCT) a profitable company?

PROCEPT BioRobotics Corporation (PRCT) has a net income of -$105.9M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 52.17% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -50.28% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $136.19M, with a revenue growth rate of 81.55%, providing insight into the company's sales performance and growth. The gross profit is $71.05M. Operating income is noted at -$109.17M. Furthermore, the EBITDA is -$104.82M.

help

What is the market capitalization of PROCEPT BioRobotics Corporation (PRCT)?

PROCEPT BioRobotics Corporation (PRCT) has a market capitalization of $4.26B. The average daily trading volume is 581.52K, indicating the stock's liquidity and investor engagement.

News

PROCEPT BIOROBOTICS

HYDROS ROBOTIC SYSTEM

PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

HEALTH

PRODUCT / SERVICES ANNOUNCEMENT

6/17/2024

PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

CALENDAR OF EVENTS

CONFERENCE CALLS/ WEBCASTS

6/3/2024

PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference

CALENDAR OF EVENTS

5/13/2024

PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference